Cytokinetics shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $5.9M | 200k | 29.46 |
| 2023-06-30 | $6.5M | 200k | 32.62 |
| 2023-03-31 | $7.0M | 205k | 34.21 |
| 2022-12-31 | $9.9M | 216k | 45.82 |
| 2022-09-30 | $9.2M | 210k | 43.66 |
| 2022-06-30 | $9.0M | 230k | 39.29 |
| 2022-03-31 | $11M | 295k | 36.81 |
| 2021-12-31 | $6.8M | 150k | 45.60 |
More positions owned by Rhenman & Partners Asset Management AB
Cigna Corp (CI)
View all positions for Rhenman & Partners Asset Management AB